SCHEMBL2880980

SCHEMBL2880980

CC1=CCC(C(=O)N(c2cc(-c3ccc(F)cc3)sc2OC(=O)O)C(C)C)CC1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 3/20 0.35
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31
MMP9 P14780 1/20 0.31
MMP8 P22894 1/20 0.31
MMP13 P45452 1/20 0.31
MMP14 P50281 1/20 0.31
PPARG P37231 1/20 0.30
PPARA Q07869 1/20 0.30
SOS1 Q07889 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2875207 0.92 KDM4E (0.33) KDM4ENPC1MAPTRAB9ASMN1; SMN2
SCHEMBL2876808 0.87 IKBKB (0.40) IKBKBKDM4ENPC1MAPTRAB9A
SCHEMBL3814842 0.85 IKBKB (0.38) IKBKBKDM4ENPC1MAPTRAB9A
SCHEMBL2878767 0.85 IKBKB (0.47) IKBKBKDM4ENPC1MAPTRAB9A
SCHEMBL3812197 0.82 HPGD (0.33) KDM4ENPC1MAPTRAB9ASMN1; SMN2
SCHEMBL2875206 0.78 KDM4E (0.36) KDM4ENPC1MAPTRAB9ASMN1; SMN2
SCHEMBL2876439 0.78 IKBKB (0.35) IKBKBKDM4ENPC1MAPTRAB9A
SCHEMBL2876340 0.78 KDM4E (0.35) KDM4ENPC1MAPTRAB9ASMN1; SMN2
SCHEMBL2874197 0.77 IKBKB (0.35) IKBKBKDM4ENPC1MAPTRAB9A
SCHEMBL2879446 0.77 GRM5 (0.36) KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569929-B9 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2011-09-14 EP claimed
EP-1569929-B1 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2010-05-05 EP claimed